SAN DIEGO, March 26, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Sana Biotechnology, Inc. (NASDAQ: SANA) securities between March 17, 2023 and November 4, 2024. Sana is a biotechnology company that develops ex vivo and in vivo…
Mon, 12 May 2025 13:09:00 GMT Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the BofA Securities ...
Tue, 06 May 2025 17:00:00 GMT LOS ANGELES, May 7, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Sana Biotechnology, Inc. ("Sana ...
Tue, 06 May 2025 12:34:00 GMT Sana Biotechnology, Inc.’s SANA share price has dipped by 5.08%, which has investors questioning if this is right time to buy.
Sun, 04 May 2025 05:53:00 GMT Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against Sana ...
Tue, 29 Apr 2025 03:45:00 GMT If you suffered a loss in Sana Biotechnology, Inc. during the relevant ... has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes ...
